Presley Gruezo-Realpe , Carlos Rodríguez-Alarcón , Danny Japón-Cueva , Linker Viñan-Paucar , Wilton Cueva-Espinoza , Josué Layedra-Luna , Javier Tomalá Haz
{"title":"Manifestaciones neuropsiquiátricas en el lupus eritematoso sistémico juvenil: estudio observacional","authors":"Presley Gruezo-Realpe , Carlos Rodríguez-Alarcón , Danny Japón-Cueva , Linker Viñan-Paucar , Wilton Cueva-Espinoza , Josué Layedra-Luna , Javier Tomalá Haz","doi":"10.1016/j.neuarg.2025.01.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Juvenile-onset systemic lupus erythematosus (SJLE) is a multisystem inflammatory disease, with involvement of neuropsychiatric manifestations (NPSLE) ranging from 37 to 95%.</div></div><div><h3>Objective</h3><div>To describe the neuropsychiatric manifestations of JLE and the factors associated with its presentation.</div></div><div><h3>Methods</h3><div>Observational, cross-sectional, retrospective, case-control, retrospective study of patients with a diagnosis of SJSLE by SLICC 2012 and American Collegue of Rheumatology (ACR) criteria seen between 2018 to 2023 in a pediatric referral hospital.</div></div><div><h3>Results</h3><div>Forty-eight patients with JESL were included, of which 28 (58.3%) presented with NPSLE and 20 (41.7%) were controls. Mean age was similar in both groups (10.8<!--> <!-->±<!--> <!-->2.96 years) and female sex predominated (78.6%). Skin symptoms were common in the NPSLE group (75%). Fever was more frequent in controls (<em>P</em>=.03), while serositis affected 75% of patients with NPSLE (<em>P</em>=.006). Leukopenia was observed in 32.1% of patients with NPSLE (<em>P</em>=.02), and anti-P ribosomal antibodies were present in 71.4% of this group, showing a significant association (<em>P</em><.001). The most common neuropsychiatric manifestations were headache (46.4%) and seizures (17.9%). Most patients in both groups had positive ANA (92.9% in NPSLE and 95% in controls). Treatment focused on hydroxychloroquine (96.4%) and other immunosuppressants such as cyclophosphamide (50%).</div></div><div><h3>Conclusions</h3><div>Neuropsychiatric manifestations in JSLE pose challenges due to their diversity and lack of consensus on their causal association. Female predominance is notable, with headache as the main symptom, but more specific classifications are needed to better understand their relationship with the disease.</div></div>","PeriodicalId":39051,"journal":{"name":"Neurologia Argentina","volume":"17 1","pages":"Pages 13-19"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurologia Argentina","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1853002825000011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Juvenile-onset systemic lupus erythematosus (SJLE) is a multisystem inflammatory disease, with involvement of neuropsychiatric manifestations (NPSLE) ranging from 37 to 95%.
Objective
To describe the neuropsychiatric manifestations of JLE and the factors associated with its presentation.
Methods
Observational, cross-sectional, retrospective, case-control, retrospective study of patients with a diagnosis of SJSLE by SLICC 2012 and American Collegue of Rheumatology (ACR) criteria seen between 2018 to 2023 in a pediatric referral hospital.
Results
Forty-eight patients with JESL were included, of which 28 (58.3%) presented with NPSLE and 20 (41.7%) were controls. Mean age was similar in both groups (10.8 ± 2.96 years) and female sex predominated (78.6%). Skin symptoms were common in the NPSLE group (75%). Fever was more frequent in controls (P=.03), while serositis affected 75% of patients with NPSLE (P=.006). Leukopenia was observed in 32.1% of patients with NPSLE (P=.02), and anti-P ribosomal antibodies were present in 71.4% of this group, showing a significant association (P<.001). The most common neuropsychiatric manifestations were headache (46.4%) and seizures (17.9%). Most patients in both groups had positive ANA (92.9% in NPSLE and 95% in controls). Treatment focused on hydroxychloroquine (96.4%) and other immunosuppressants such as cyclophosphamide (50%).
Conclusions
Neuropsychiatric manifestations in JSLE pose challenges due to their diversity and lack of consensus on their causal association. Female predominance is notable, with headache as the main symptom, but more specific classifications are needed to better understand their relationship with the disease.
期刊介绍:
Neurología Argentina es la publicación oficial de la Sociedad Neurológica Argentina. Todos los artículos, publicados en español, son sometidos a un proceso de revisión sobre ciego por pares con la finalidad de ofrecer información original, relevante y de alta calidad que abarca todos los aspectos de la Neurología y la Neurociencia.